Mental Health Book

http://www.fpnotebook.com/

Fluvoxamine

Aka: Fluvoxamine, Luvox
  1. Mechanism
    1. Selective Serotonin Reuptake Inhibitor (SSRI)
  2. Background
    1. Generic in 2001
  3. Indications
    1. Obsessive Compulsive Disorder (OCD)
  4. Dosing
    1. Adults
      1. Start: 25 mg (half of 50 mg tablet) qhs for 3 days
      2. Next: 50 mg PO qhs for 7 days
      3. Next: 50 mg PO bid OR 100 qhs
      4. Titrate to 150 - 250 mg daily divided bid
    2. Children (Age 8 years or older)
      1. Start: 25 mg PO qhs
      2. Maximum: 200 mg divided bid
  5. Pharmacokinetics
    1. Serum half life: 19 hours
  6. Adverse Effects
    1. Sedating
    2. Highest Nausea and Vomiting frequency
    3. Less anxiety (more Anxiolytic) than other SSRIs
    4. Less Sexual Dysfunction than Prozac, Zoloft, Paxil
      1. Sexual dysfunction in 10-15% of cases
      2. Similar to Celexa and Effexor
      3. See Antidepressant Induced Sexual Dysfunction
  7. Drug Interactions
    1. Inhibits Cytochrome P450-1A and P450-3A
      1. Avoid with Theophylline (risk of toxicity)
      2. Increases caffeine half life
    2. Raises Tricyclic Antidepressant levels
    3. Raises Warfarin (Coumadin) and associated INR levels
    4. Other interactions
      1. Seldane
      2. Hismanal
      3. Xanax
  8. Precautions
    1. Relatively safe
    2. Avoid in Hepatic and Renal insufficiency
    3. Avoid in pregnancy and Lactation
    4. No Overdose

Luvox (C0086307)

Definition (NCI) A drug used to treat obsessive-compulsive disorder. It is a type of antidepressant agent and selective serotonin reuptake inhibitor (SSRI).
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D016666
English luvox, Luvox, Faverin, Dumirox, Fevarin, Floxyfral, Solvay Brand of Fluvoxamine Maleate
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Fluvoxamine (C0085228)

Definition (NCI) A drug used to treat obsessive-compulsive disorder. It is a type of antidepressant agent and selective serotonin reuptake inhibitor (SSRI).
Definition (MSH) A selective serotonin reuptake inhibitor. It is effective in the treatment of depression, obsessive-compulsive disorders, anxiety, panic disorders, and alcohol amnestic disorders.
Definition (CSP) selective serotonin reuptake inhibitor effective in treatment of depression, obsessive compulsive disorders, anxiety, panic disorders, and alcohol amnestic disorders.
Definition (NCI) A 2-aminoethyl oxime ether of aralkylketones, with antidepressant, antiobsessive-compulsive, and anxiolytic properties. Fluvoxamine, chemically unrelated to other selective serotonin reuptake inhibitors, selectively blocks serotonin reuptake by inhibiting the serotonin reuptake pump at the presynaptic neuronal membrane. This increases serotonin levels within the synaptic cleft, prolongs serotonergic transmission and decreased serotonin turnover, thereby leading to antidepressant, anxiolytic and antiobsessive-compulsive effects. Fluvoxamine shows no significant affinity for histaminergic, alpha or beta adrenergic, muscarinic, or dopaminergic receptors in vitro.
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D016666
SnomedCT 372905008, 96213009
English Fluvoxamine, 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, FLUVOXAMINE, fluvoxamine, Fluvoxamine [Chemical/Ingredient], fluvoxaMINE, Fluvoxamine (product), Fluvoxamine (substance), Fluoxamine
Swedish Fluvoxamin
Czech fluvoxamin
Finnish Fluvoksamiini
Russian FLUVOKSAMIN, ФЛУВОКСАМИН
Japanese フルボキサミン
Polish Fluwoksamina
Spanish fluvoxamina (producto), fluvoxamina (sustancia), fluvoxamina, Fluvoxamina
French Fluvoxamine
German Fluvoxamin
Italian Fluvoxamina
Portuguese Fluvoxamina
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree